Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
John Sheppard, Mark Bergmann, Barry A Schechter, Jodi Luchs, Abayomi Ogundele & Paul Karpecki. (2021) Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca. Clinical Ophthalmology 15, pages 129-140.
Read now
Read now
Michele Figus, Luca Agnifili, Manuela Lanzini, Lorenza Brescia, Francesco Sartini, Leonardo Mastropasqua & Chiara Posarelli. (2021) Topical preservative-free ophthalmic treatments: an unmet clinical need. Expert Opinion on Drug Delivery 18:6, pages 655-672.
Read now
Read now
Articles from other publishers (11)
Yi-Chen Sun, Li-Li Wu, Yu-An Chang, Tzu-Yun Li, Yang Lin, Fung-Rong Hu, Wei-Bor Tsai & Kai-Feng Hung. (2022) Zwitterionic poly(carboxybetaine methacrylate) (polyCBMA) decreases desiccating damage to corneal epithelial cells. Colloid and Interface Science Communications 50, pages 100648.
Crossref
Crossref
Alireza Shoari, Mozhgan Rezaei Kanavi & Mohammad Javad Rasaee. (2021) Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study. Experimental Eye Research 205, pages 108523.
Crossref
Crossref
Ali Hassan, Shafi Balal & Sajjad Ahmad. (2020) Meibomian gland dysfunction, dropout and distress: emerging therapies. Eye 34:9, pages 1494-1496.
Crossref
Crossref
John Sheppard, Shane Kannarr, Jodi Luchs, Ranjan Malhotra, Angela Justice, Abayomi Ogundele, Charles Darby & Jason Bacharach. (2020) Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study. Eye & Contact Lens: Science & Clinical Practice 46:1, pages S14-S19.
Crossref
Crossref
Brian K. Armstrong, Ivana Romac Coc, Prateek Agarwal, Scott Smith & Samuel Navon. (2019) Association of Ramadan daytime fasting with ocular surface inflammation and dry eye. International Ophthalmology 39:12, pages 2857-2863.
Crossref
Crossref
Yu-Kai Kuo, I-Chan Lin, Li-Nien Chien, Tzu-Yu Lin, Ying-Ting How, Ko-Hua Chen, Gregory J. Dusting & Ching-Li Tseng. (2019) Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits. Journal of Clinical Medicine 8:8, pages 1227.
Crossref
Crossref
Di Chen, Shunhua Zhang, Ailing Bian, Jing Hong, Yingping Deng, Mingchang Zhang, Wei Chen, Yan Shao & Jialiang Zhao. (2019) Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study. Medicine 98:31, pages e16710.
Crossref
Crossref
Erin C. O’Neil, Matthew Henderson, Mina Massaro-Giordano & Vatinee Y. Bunya. (2019) Advances in dry eye disease treatment. Current Opinion in Ophthalmology 30:3, pages 166-178.
Crossref
Crossref
Abhirup Mandal, Vrinda Gote, Dhananjay Pal, Abayomi Ogundele & Ashim K. Mitra. (2019) Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease. Pharmaceutical Research 36:2.
Crossref
Crossref
Jesus Alvarez-Trabado, Antonio López-García, Manuel Martín-Pastor, Yolanda Diebold & Alejandro Sanchez. (2018) Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation. International Journal of Pharmaceutics 546:1-2, pages 20-30.
Crossref
Crossref
Michelle K. Rhee & Francis S. Mah. (2017) Inflammation in Dry Eye Disease. Ophthalmology 124:11, pages S14-S19.
Crossref
Crossref